![Robert Georgantas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Georgantas
Geen lopende functies
Profiel
Robert W.
Georgantas worked at Biodesix, Inc. from 2019 to 2023 as Senior VP-Research & Translational Science.
From 2023 to 2024, worked at Providence Therapeutics, Inc. as President & Chief Technology Officer.
Dr. Georgantas earned a doctorate from The Johns Hopkins University School of Medicine.
Eerdere bekende functies van Robert Georgantas
| Bedrijven | Functie | Einde |
|---|---|---|
Providence Therapeutics, Inc.
 Providence Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative immunotherapeutic for cancer treatment | President | 01-03-2024 |
| BIODESIX, INC. | Corporate Officer/Principal | 01-02-2023 |
Opleiding van Robert Georgantas
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
13
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Biodesix, Inc.
 Biodesix, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic research and clinical trial testing services & engages in discovery, development and commercialization of therapeutics | Health Services |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Providence Therapeutics, Inc.
Providence Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative immunotherapeutic for cancer treatment | Health Technology |
